EnglishFrenchGermanItalianSpanish

Location

PARTNERS
See Our Partners
NEWSROOM

DISCOVER WHAT WE ARE DOING

READ ALL ABOUT IT
GENERAL INQUIRIES

If you have questions, comments or need more information from our team, please fill out the form below and we will get back to you. Follow us on our social media to see our latest updates and job opportunities.


 
 

Contact Details

Please provide the following information for the person who experienced the issue:

General Information

DeathSerious adverse eventAdverse event (not serious)Product Problem (defects/malfunctions)Out of service/safety issueProduct use errorLabeling issue
 
 
Initial use of assayRe-use of of instrumentRe-serviced/refurbishedProblem noted prior useDuplicate issueOther (please specify)
TreatmentEvaluation
False negative resultIncorrect qualification of the infection/Unclear resultsFalse positive resultDelayed reporting of resultsOther, please specify

If available, email to: techsupport@neumodx.com (Include compliant in the subject line)

Product Details

Assay, Reagents and Consumables

Instruments

Action Taken


Coronavirus Assay Information

NeuMoDx™ Molecular, a sample-to-result molecular diagnostic company focused on providing testing solutions to hospital and commercial reference laboratories, has developed a SARS-CoV-2 Assay for use on the high throughput, fully automated NeuMoDx™ 288 and 96 Molecular Systems. The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the NeuMoDx™ SARS-CoV-2 Assay implemented on the NeuMoDx™ Molecular Systems.

To learn more about SARS-CoV-2 testing, click here.
To order, click here.